Publications by authors named "Cheila Brito"

Claim this Profile
B
BRD9 status is a major contributor for cysteine metabolic remodeling through MST and EAAT3 modulation in malignant melanoma.
Ana Hipólito, Renato Xavier, Cheila Brito, Ana Tomás, Isabel Lemos

Biochim Biophys Acta Mol Basis Dis· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Mutations in Diffuse Gliomas: An Update on Molecular Stratification, Prognosis, Recurrence, and Aggressiveness.
Cheila Brito, Ana Tomás, Ana Azevedo, Susana Esteves, Manuela Mafra

Clin Med Insights Oncol· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unraveling the Relevance of ARL GTPases in Cutaneous Melanoma Prognosis through Integrated Bioinformatics Analysis.
Cheila Brito, Bruno Costa-Silva, Duarte C Barral, Marta Pojo

Int J Mol Sci· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Impact of Olive Oil Compounds on the Metabolic Reprogramming of Cutaneous Melanoma Cell Models.
Cheila Brito, Ana Tomás, Sandra Silva, Maria Rosário Bronze, Ana Teresa Serra

Molecules· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Subversion of Ras Small GTPases in Cutaneous Melanoma Aggressiveness.
Cheila Brito, Duarte C Barral, Marta Pojo

Front Cell Dev Biol· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Melanoma Metabolism: Cell Survival and Resistance to Therapy.
Rafael Luís, Cheila Brito, Marta Pojo

Adv Exp Med Biol· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-Throughput Sequencing Identifies 3 Novel Susceptibility Genes for Hereditary Melanoma.
Catarina Campos, Sofia Fragoso, Rafael Luís, Filipe Pinto, Cheila Brito

Genes (Basel)· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical insights gained by refining the 2016 WHO classification of diffuse gliomas with: EGFR amplification, TERT mutations, PTEN deletion and MGMT methylation.
Cheila Brito, Ana Azevedo, Susana Esteves, Ana Rita Marques, Carmo Martins

BMC Cancer· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis